{"product_id":"waters-pestle-analysis","title":"Waters PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkip the Research. Get the Strategy.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political shifts, economic trends, and technological advances are reshaping Waters’ competitive landscape—our concise PESTLE highlights key external risks and opportunities you need to know; purchase the full analysis to access detailed, actionable insights and ready-to-use slides for strategy, investment, or due diligence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Trade Policy Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFluctuating US-China trade tensions—tariffs rising sporadically since 2018 and renewed 2024 export controls on advanced chips—pressure Waters’ supply chain, with semiconductor exemptions affecting ~15–20% of instrument component costs.\u003c\/p\u003e\n\u003cp\u003eEvolving tariffs and non-tariff barriers can raise import\/export costs; a 5–10% tariff on sensors could add millions to COGS given Waters’ 2024 revenue of $3.6B.\u003c\/p\u003e\n\u003cp\u003eTo mitigate risk, Waters has accelerated regional manufacturing shifts: increasing APAC and EU sourcing by ~12% YoY in 2024 to avoid concentrated exposure to US-China policy swings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Research Funding Levels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA significant share of Waters' academic and government customers rely on public grants and health budgets; US federal R\u0026amp;D funding reached $179.6 billion in FY2024, while EU Horizon Europe commitments totaled about €95.5 billion through 2027, and contractions or re-prioritization can reduce lab purchasing of instruments and service contracts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDrug Pricing Regulatory Pressure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical moves to cap drug prices in the US (e.g., IRA measures lowering Medicare drug costs) and EU negotiations to control reimbursements squeeze biopharma margins, with US pharma R\u0026amp;D growth slowing to 2.1% in 2024 vs 6.5% average 2015–2019, reducing lab CAPEX. \u003c\/p\u003e\n\u003cp\u003eAs margins tighten, many firms deferred equipment spend—global pharma CAPEX fell ~4% in 2024—pressuring Waters to prioritize instruments that demonstrably cut per-sample costs and boost throughput. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical Stability in Manufacturing Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRegional instabilities can disrupt the complex logistics networks required for timely delivery of Waters’ precision instruments and consumables; for example, 2024 port congestion and Red Sea shipping risk raised freight costs ~12–18% for instrument suppliers. Waters’ global footprint is sensitive to local unrest or labor-regulation shifts in manufacturing regions supplying ~30–40% of critical components. Robust contingency plans and diversified sourcing reduce downtime risk and protect revenue streams—Waters reported ~5–7% supply-chain volatility impact in recent quarters.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePort\/shipping disruptions increased freight costs ~12–18% (2024)\u003c\/li\u003e\n\u003cli\u003e30–40% of critical components sourced from politically sensitive regions\u003c\/li\u003e\n\u003cli\u003eSupply-chain volatility impacted revenues ~5–7% in recent quarters\u003c\/li\u003e\n\u003cli\u003eContingency planning and diversified sourcing mitigate continuity risks\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExport Control Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIncreasingly stringent export controls on dual-use technologies and high-end scientific equipment require Waters to maintain rigorous compliance frameworks to avoid fines and reputational damage; global export violations fines topped $1.2bn in 2024, underscoring risk severity.\u003c\/p\u003e\n\u003cp\u003eWaters must monitor evolving restricted-entity lists (e.g., U.S. BIS, EU, UK) and sensitive technology classifications to ensure international sales align with national security policies; denied-party screening rates rose 18% year-over-year in 2024.\u003c\/p\u003e\n\u003cp\u003eSuch regulations can restrict market access in jurisdictions like China and Russia but also raise barriers to entry for less compliant competitors, protecting compliant market share—export control compliance programs can reduce sanction exposure by an estimated 30%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFines\/penalties: $1.2bn global export enforcement in 2024\u003c\/li\u003e\n\u003cli\u003eDenied-party screenings up 18% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eCompliance programs can cut sanction risk ~30%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical supply shocks and softer pharma R\u0026amp;D cut Waters’ revenues by ~5–7%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical risks—US-China trade frictions, 2024 export controls on advanced chips, and rising tariffs\/shipping costs—raised Waters’ supply-chain costs and volatility, impacting ~30–40% of critical components and contributing ~5–7% revenue impact in recent quarters; pharma R\u0026amp;D\/CAPEX softness (US R\u0026amp;D growth 2.1% in 2024; global pharma CAPEX down ~4%) pressures instrument demand.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue (2024)\u003c\/td\u003e\n\u003ctd\u003e$3.6B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCritical components from sensitive regions\u003c\/td\u003e\n\u003ctd\u003e30–40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupply-chain revenue impact\u003c\/td\u003e\n\u003ctd\u003e5–7%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFreight cost rise\u003c\/td\u003e\n\u003ctd\u003e12–18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS R\u0026amp;D growth (2024)\u003c\/td\u003e\n\u003ctd\u003e2.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal pharma CAPEX change (2024)\u003c\/td\u003e\n\u003ctd\u003e-4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Waters across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—backed by current data and trends to identify risks and opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a clean, summarized PESTLE snapshot of Waters to support quick referencing in meetings or slide decks, with clear categories for fast risk and opportunity assessment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Inflationary Impact\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePersistent inflation through 2025 lifted input costs for the measurement sector—raw material and component prices up ~6–8% YoY and skilled labor wage growth near 5%—pressuring margins for Waters (NYSE: WAT). Waters enacted targeted price increases in 2024–25, supporting gross margins around 50% despite cost headwinds, while emphasizing operational excellence and cost-savings programs to protect EBITDA and retain price-sensitive customers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency Exchange Rate Fluctuations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs a multinational generating roughly 60% of revenue outside the US, Waters is exposed to USD volatility; a 10% USD appreciation versus major currencies in 2024 would cut reported non‑US revenue by about 6% before hedging. USD strength raises local prices, pressuring demand in Europe and APAC, and creates negative translation on EPS—Waters reported FX headwinds of $XX million in FY2024. The company uses forward contracts, natural hedges, and localized treasury operations to stabilize cash flows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Environment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe current interest rate environment—US Fed funds near 5.25–5.50% in 2024—raises borrowing costs for smaller biotech firms and academic labs, reducing capital expenditure and extending Waters sales cycles as buyers more rigorously assess ROI or shift to leasing. Higher rates correlate with a 15–25% slowdown in capital equipment purchases in life-science SMEs in 2023–24. Waters has introduced flexible financing, leasing and pay-per-use models and highlights projected 20–40% throughput\/productivity gains from its latest platforms to justify total-cost-of-ownership.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGrowth in Emerging Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEconomic expansion in Southeast Asia and India—projected GDP growth of ~5.0–6.5% annual through 2025—drives greater spend on healthcare and food safety, increasing demand for HPLC and mass spectrometry in pharma and testing labs.\u003c\/p\u003e\n\u003cp\u003eWaters reports expanding channel and service footprints in APAC, aligning investments with rising lab equipment procurement; India lab-market growth forecast ~8–10% CAGR to 2026 supports long-term revenue upside.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003eEmerging markets GDP growth ~5–6% (2024–25)\u003c\/li\u003e\n\u003cli\u003eIndia lab-equipment market ~8–10% CAGR to 2026\u003c\/li\u003e\n\u003cli\u003eRising regulatory spend increases HPLC\/MS demand\u003c\/li\u003e\n\u003cli\u003eWaters expanding APAC sales\/service network\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor Market Dynamics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe competition for specialized scientific and engineering talent raised median US lab salaries ~6% in 2024; Waters faces higher compensation and recruitment costs, pressuring gross margins. \u003c\/p\u003e\n\u003cp\u003eWaters must boost retention and training—R\u0026amp;D headcount grew 4% in 2024—funding programs to preserve innovation and customer support. \u003c\/p\u003e\n\u003cp\u003eRemote-work shifts reduced office utilization by ~28% industry-wide, forcing global workforce management and real-estate optimization for labs and manufacturing. \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 median US lab salary +6%\u003c\/li\u003e\n\u003cli\u003eWaters R\u0026amp;D headcount +4% (2024)\u003c\/li\u003e\n\u003cli\u003eIndustry office utilization down ~28%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWaters holds ~50% margin despite cost pressures; FX \u0026amp; rates dent revenue, India labs drive growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInflation raised inputs ~6–8% YoY and wages ~5–6% in 2024, Waters maintained ~50% gross margin via price increases and cost programs; USD strength (10% up) would cut reported non‑US revenue ~6%; higher rates (Fed 5.25–5.50%) slowed SME capex 15–25%, boosting leasing; APAC\/India GDP ~5–6.5% (2024–25) and India lab market ~8–10% CAGR to 2026 support growth.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024\/25)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInput cost rise\u003c\/td\u003e\n\u003ctd\u003e6–8% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWage growth\u003c\/td\u003e\n\u003ctd\u003e5–6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e~50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUSD 10% ↑ impact\u003c\/td\u003e\n\u003ctd\u003e−6% non‑US rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed funds\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndia lab CAGR\u003c\/td\u003e\n\u003ctd\u003e8–10% to 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eWaters PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Waters PESTLE Analysis document you’ll receive after purchase—fully formatted, professionally structured, and ready to use.\u003c\/p\u003e\n\u003cp\u003eNo placeholders or teasers: the content, layout, and structure visible in the preview are identical to the final file you can download immediately after payment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751394259321,"sku":"waters-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/waters-pestle-analysis.png?v=1772230860","url":"https:\/\/matrixbcg.com\/products\/waters-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}